Mersen SA (MRN)
Euronext Paris · France · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 37.42 |
|---|---|
| 52-week range | 20.35 – 45.36 |
| Return, 1 month / 3 months | −8.8% / +6.4% |
| Return, 1 year / 3 years | +68.8% / +36.3% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 45 |
| Volatility (1 year) | 41.9% |
| Worst drawdown (1 year) | -22.8% |
| Average daily value traded | 1.39M EUR |
| Dividend yield | 2.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Mersen is a French industrial group that makes graphite and carbon-based products and electrical protection equipment. Its carbon and graphite materials are used in motor brushes, heat exchangers and high-temperature industrial components, while its electrical division supplies fuses, surge protection devices and busbars. Customers are mainly industrial manufacturers and energy, electronics and process-industry companies, and the group is based in France with operations across Europe, North America and Asia.
On this site Mersen SA appears as a stock on the Euronext Paris (France), code MRN, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Mersen SA (MRN) trades on the Euronext Paris in France. It last closed at EUR 37.42 on 27 October 2026.
Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 44 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 68.8% and over the last three months it rose 6.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 85 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 10.6% | ||
| From 52-week high | -16.5% | ||
| Momentum | 92 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 6.4% | ||
| 6-month return | 34.4% | ||
| 12-month return, skipping the last month | 85.1% | ||
| Stability (higher is calmer) | 61 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 41.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.8% | ||
| Liquidity | 80 · Strong | Trades actively. | |
| Average daily value traded | 1.39M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 42 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.4% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.1% |
|---|---|
| 1 month | −8.8% |
| 3 months | +6.4% |
| 6 months | +34.4% |
| 1 year | +68.8% |
| 3 years | +36.3% |
| 5 years | +44.5% |
Signals
| 50-day / 200-day average | 38.92 / 33.83 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.51 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Jul 2026 | EUR 0.9000 |
| 7 Jul 2025 | EUR 0.9000 |
| 2 Jul 2024 | EUR 1.2500 |
| 4 Jul 2023 | EUR 1.2500 |
| 5 Jul 2022 | EUR 1.0000 |
| 6 Jul 2021 | EUR 0.6500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.